Q4 2025 Earnings Call February 17, 2026 4:30 PM ESTCompany ParticipantsSteven Zenker - Vice President of Investor RelationsDaniel ...

Q2 2026 Earnings Call February 16, 2026 6:01 PM ESTCompany ParticipantsStephen Mikkelsen - Group CEO, Director & MDWarrick R.

AXPAXLI (TM) (also known as OTX-TKI) is an investigational, bioresorbable, intravitreal hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase inhibitor with anti-angiogenic ...

First ever successful demonstration of superiority in an FDA-aligned wet AMD trial comparing a novel investigative agent to an approved anti-VEGF ...

(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today ...

SHENZHEN, GUANGDONG, CHINA, January 22, 2026 /EINPresswire.com/ -- The global transportation sector in 2026 has reached ...

For many years, disability was largely absent from technology policy debates. Yet, a deeper issue remains insufficiently examined: accessibility alone does not ensure inclusion when artificial ...

EPAM Systems, Inc. , a leading digital and AI transformation company, today announced the North American launch of Empathy Lab by EPAM, its AI-native agency designed to help brands build intelligent, ...

Arizona Sonoran Copper Company Inc. today announces that ASCU and Nuton LLC , a Rio Tinto Venture, have mutually agreed to ...

Before we begin, we would like to remind everyone that today's prepared remarks contain forward-looking statements and management may make additional forward-looking statements in response to your ...

With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology advances.

A detailed annotation of anatomical brain structures (some novel) of the spider Uloborus diversus is provided based on a ...